2m 2m 2m 2m 2m 2m 2m
NEXTCURE (NXTC)
NASDAQ
$4.74-$0.67 (-12.47%)
Price as of Oct 22, 2026 7:30 PM EDT- $24.8MMarket Cap
- -40.03%1-Year Change
- BiotechnologyIndustry
NEXTCURE (NXTC)
$4.74-$0.67 (-12.47%)
NXTC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.42 | ||
Change | -$0.03 (-0.46%) | ||
Open | $5.51 | ||
High | $6.04 | ||
Low | $5.25 | ||
Previous Close | $5.44 | ||
Volume | 71,520 | ||
30-Day Average Volume | 89,321 | ||
1-Week Change | -17.71% | ||
1-Month Change | -0.82% | ||
1-Year Change | -40.03% | ||
3-Year Change | -65.02% | ||
5-Year Change | -94.68% | ||
Fundamentals | |||
Shares Outstanding | 4.6M | ||
Total Assets | $22.6M | ||
Market Cap | $24.8M | ||
Enterprise Value | $9.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$14.9M | ||
Free Cash Flow | -$9.7M | ||
EBIT | -$14.9M | ||
EBITDA | -$14.9M | ||
Net Working Capital | $15.8M | ||
EPS | -$2.80 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 07/14/2025 | ||
Earnings & Revenue